-+ 0.00%
-+ 0.00%
-+ 0.00%
Kintor Pharmaceutical Receives Chinese Patent Grant for KT-939
Share
Listen to the news
Kintor Pharmaceutical Receives Chinese Patent Grant for KT-939
  • Kintor Pharmaceutical received a Chinese invention patent grant notice for KT-939 on Oct. 21, 2026, covering a tyrosinase inhibitor and its uses.
  • KT-939 targets the high-end cosmetic raw materials market for skin whitening and freckle removal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12390226), on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending